Trial intelligence / Profile preview

Tacrolimus cream in plaque psoriasis

NCT00293930Phase 3Completed

Sponsor
Astellas Pharma
Modality
RNA-Targeting Small Molecules
Countries
2
01

Overview

A Phase 3 trial of tacrolimus in plaque psoriasis, sponsored by Astellas Pharma. Status: completed.

02

Drugs

tacrolimus
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT00293930.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00293930.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call